Journal list menu
Export Citations
Download PDFs
Issue Information
Hepatology Highlights
Master's Perspective
Free Access
free
What have we learned about intrahepatic cholestasis of pregnancy?
- Pages: 4-8
- First Published: 16 October 2015
Comments from the Editors
Editorials
Free Access
free
Flunarizine arrests hepatitis C virus membrane fusion
- Pages: 14-16
- First Published: 21 September 2015
Free Access
free
Liver receptor homolog 1 and transmethylation fluxes in nonalcoholic steatohepatitis
- Pages: 17-19
- First Published: 03 September 2015
Free Access
free
High prevalence of hepatic fibrosis in the setting of coexisting diabetes and hepatic steatosis: A case for selective screening in the general population?
- Pages: 20-22
- First Published: 09 October 2015
Free Access
free
Circulating tumor cells and cholangiocarcinoma
- Pages: 23-25
- First Published: 11 September 2015
Free Access
free
Could gut microbiota protect against sclerosing cholangitis?
- Pages: 26-27
- First Published: 27 August 2015
Free Access
free
No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL
- Pages: 28-30
- First Published: 16 October 2015
Free Access
free
AASLD practice guidelines: The past, the present, and the future
- Pages: 31-34
- First Published: 13 November 2015
Viral Hepatitis
Free Access
free
A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses
- Pages: 35-48
- First Published: 29 July 2015
Free Access
free
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
- Pages: 49-62
- First Published: 06 August 2015
Free Access
free
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3
- Pages: 63-73
- First Published: 25 September 2015
Free Access
free
Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood
- Pages: 74-82
- First Published: 21 September 2015
Free Access
free
Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B
- Pages: 83-94
- First Published: 12 October 2015
Steatohepatitis/Metabolic Liver Disease
Free Access
free
Liver receptor homolog-1 is a critical determinant of methyl-pool metabolism
- Pages: 95-106
- First Published: 12 August 2015
Free Access
free
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
- Pages: 107-116
- First Published: 16 October 2015
Free Access
free
Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study
- Pages: 117-125
- First Published: 12 October 2015
Free Access
free
Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin
- Pages: 126-137
- First Published: 25 September 2015
Free Access
free
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study
- Pages: 138-147
- First Published: 14 July 2015
Hepatobiliary Malignancies
Free Access
free
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
- Pages: 148-158
- First Published: 19 June 2015
Free Access
free
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma
- Pages: 159-172
- First Published: 21 September 2015
Free Access
free
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
- Pages: 173-184
- First Published: 24 September 2015
Autoimmune, Cholestatic and Biliary Disease
Free Access
free
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
- Pages: 185-196
- First Published: 04 June 2015
Liver Failure/Cirrhosis/Portal Hypertension
Free Access
free
Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension
- Pages: 197-206
- First Published: 30 September 2015
Free Access
free
Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats
- Pages: 207-216
- First Published: 24 September 2015
Liver Biology/Pathobiology
Free Access
free
Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis
- Pages: 217-232
- First Published: 08 October 2015
Free Access
free
Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver
- Pages: 233-246
- First Published: 16 October 2015
Free Access
free
Hepatocyte homeostasis for chromosome ploidization and liver function is regulated by Ssu72 protein phosphatase
- Pages: 247-259
- First Published: 12 October 2015
Liver Capsule
Free Access
free
Liver capsule: Age-influenced hepatic immune priming determines HBV infection fate: Implications from mouse to man
- Page: 260
- First Published: 12 October 2015
Practice Guideline
Free Access
free
AASLD guidelines for treatment of chronic hepatitis B
- Pages: 261-283
- First Published: 13 November 2015
Reviews
Free Access
free
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
- Pages: 284-306
- First Published: 13 November 2015
Free Access
free
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis
- Pages: 307-318
- First Published: 13 November 2015
Free Access
free
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis
- Pages: 319-333
- First Published: 13 November 2015
Hepatology Elsewhere
Free Access
free
Breaking the species barrier for hepatitis delta virus
- Pages: 334-336
- First Published: 20 August 2015
Free Access
free
Cirrhosis and dysbiosis: New insights from next-generation sequencing
- Pages: 336-338
- First Published: 27 August 2015
Clinical Observations in Hepatology
Free Access
free
Fecal microbiota transplantation in the management of hepatic encephalopathy
- Pages: 339-340
- First Published: 11 August 2015
Correspondence
Free Access
free
Telomerase reverse transcriptase promoter methylation is related to a risk of recurrence in hepatocellular carcinoma
- Page: 341
- First Published: 04 April 2015
Free Access
free
Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see
- Pages: 342-343
- First Published: 30 April 2015
Free Access
free
Model for end-stage liver disease-based allocation system: On the right path, but not there yet
- Page: 344
- First Published: 22 March 2015
Free Access
free
Hepatocellular carcinoma: To resect or to transplant?
- Pages: 344-345
- First Published: 29 May 2015
Free Access
free
Serum alkaline phosphatase in multidrug resistance 2 (Mdr2–/–) knockout mice is strain specific
- Page: 346
- First Published: 30 April 2015
Free Access
free
Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China
- Pages: 347-348
- First Published: 07 May 2015
Corrections
Free Access
free
Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors
- Page: 349
- First Published: 21 December 2015
Free Access
free
Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor–induced epithelial-mesenchymal transition
- Page: 349
- First Published: 21 December 2015
Free Access
free
Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis
- Page: 349
- First Published: 21 December 2015